All In MedTech

FDA Clearance Tracker · DEN250044

Queen of Hearts (ACS AI ECG Model)

A De Novo grant creates a new device type for a low to moderate risk device with nothing on the market to compare it to. Later devices of this type can use it as their comparison in a 510(k).

Last checked: Nov 19, 2026Latest source record: Sep 3, 2026 (this decision)Source: openFDAMethods & limitations

De NovoNew device type

Decided

Sep 3, 2026

De Novo granted

Time to decision

346 days

Received Sep 22, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

De Novo

Direct

Device class

Not stated

The decision

FDA number
DEN250044
Device name
Queen of Hearts (ACS AI ECG Model)
Applicant location
New York, NY
Received
Sep 22, 2025
Decided
Sep 3, 2026
Decision
De Novo granted
Submission type
Direct

Device type

Specialty
Cardiology

Every decision under product code SHS

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Powerful Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.